Flex Pharma, Inc., a biopharmaceutical company that is developing innovative and proprietary treatments for nocturnal leg cramps and other severe neuromuscular conditions, today announced that Marc Kozin and Stuart Randle have joined the company's Board of Directors.
“With their breadth and depth of experience in healthcare, Marc and Stu will provide a tremendous resource as we endeavor to develop solutions for patients with severe neuromuscular disorders,” commented Flex Pharma Co-Founder, Co-Chair of the Company’s Scientific Advisory Board and Nobel Laureate, Rod MacKinnon, M.D.
Help employers find you! Check out all the jobs and post your resume.
“With their breadth and depth of experience in healthcare, Marc and Stu will provide a tremendous resource as we endeavor to develop solutions for patients with severe neuromuscular disorders,” commented Flex Pharma Co-Founder, Co-Chair of the Company’s Scientific Advisory Board and Nobel Laureate, Rod MacKinnon, M.D.
Help employers find you! Check out all the jobs and post your resume.
